Cisen Pharmaceutical Co Ltd
603367
Company Profile
Business description
Cisen Pharmaceutical Co Ltd is the pharmaceutical company in China. The company's main business is the development, production and sales of pharmaceutical products, mainly in the production of chemical preparations. Its product offering includes chemical drug preparations such as liver disease drug, antitumor and auxiliary drugs, nutrition preparation, cardiovascular class, antibiotics, sedation anaesthesia snooze, digestive system agents; and healthcare products.
Contact
Tongji Sci-tech Industrial Park
High-tech Industrial Development Zone
Shandong
Jining272073
CHNT: +86 5372980071
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
3,302
Stocks News & Analysis
stocks
Oracle shares are up 87% in 2025. Is it a buy?
Oracle’s cloud database business is riding the AI wave.
stocks
Is there a long-term buying opportunity in luxury stocks?
Our analysts think the recent wobble in revenue growth is cyclical, not structural.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,137.80 | 14.90 | 0.16% |
| CAC 40 | 7,884.11 | 54.00 | 0.69% |
| DAX 40 | 23,586.56 | 59.51 | 0.25% |
| Dow JONES (US) | 46,381.54 | 66.27 | 0.14% |
| FTSE 100 | 9,238.05 | 11.37 | 0.12% |
| HKSE | 26,159.12 | 185.02 | -0.70% |
| NASDAQ | 22,788.98 | 157.50 | 0.70% |
| Nikkei 225 | 45,493.66 | 447.85 | 0.99% |
| NZX 50 Index | 13,136.54 | 5.00 | -0.04% |
| S&P 500 | 6,693.75 | 29.39 | 0.44% |
| S&P/ASX 200 | 8,845.90 | 14.30 | 0.16% |
| SSE Composite Index | 3,821.83 | 6.74 | -0.18% |